Creative Medical Technology Holdings, Inc. (CELZ) is a commercial-stage biotechnology company developing regenerative therapies across immunotherapy, endocrinology, urology, neurology, and orthopedics. Key platforms include ImmCelz (CELZ-100), an autologous immune cell reprogramming therapy; AlloStem (CELZ-201), an allogenic cell line used in Type 1 Diabetes and chronic lower back pain trials; StemSpine for lower back pain; and an iPSC program (iPSCelz) developed with Greenstone Biosciences. The company operates through subsidiaries CMT, ImmCelz Inc., StemSpine Inc., and AlloCelz LLC.
expected 2026-11-30
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-20 | 2025-12-31 | 0001477932-26-001517 | EDGAR | 43K words |
| 2025-03-14 | 2024-12-31 | 0001477932-25-001736 | EDGAR | 40K words |
| 2024-03-22 | 2023-12-31 | 0001477932-24-001431 | EDGAR | 40K words |
| 2023-03-31 | 2022-12-31 | 0001477932-23-002123 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001477932-22-001741 | EDGAR | — |
| 2021-03-17 | 2020-12-31 | 0001477932-21-001495 | EDGAR | — |
| 2020-04-06 | 2019-12-31 | 0001104659-20-043660 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001144204-19-017462 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001144204-18-017967 | EDGAR | — |
| 2017-02-13 | 2016-12-31 | 0001144204-17-007873 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001477932-26-004779 | EDGAR | 15K words |
| 2025-11-07 | 2025-09-30 | 0001477932-25-007978 | EDGAR | 14K words |
| 2025-08-08 | 2025-06-30 | 0001477932-25-005614 | EDGAR | 14K words |
| 2025-05-09 | 2025-03-31 | 0001477932-25-003498 | EDGAR | 12K words |
| 2024-11-08 | 2024-09-30 | 0001477932-24-006991 | EDGAR | 15K words |
| 2024-08-09 | 2024-06-30 | 0001477932-24-004635 | EDGAR | 15K words |
| 2024-05-10 | 2024-03-31 | 0001477932-24-002695 | EDGAR | 12K words |
| 2023-11-14 | 2023-09-30 | 0001477932-23-008458 | EDGAR | 15K words |
| 2023-08-11 | 2023-06-30 | 0001477932-23-005935 | EDGAR | 15K words |
| 2023-05-12 | 2023-03-31 | 0001477932-23-003347 | EDGAR | 13K words |
| 2022-11-10 | 2022-09-30 | 0001477932-22-008323 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001477932-22-005931 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-25 | 0001477932-26-005805 | EDGAR | 2K words |
| 2026-08-31 | 0001477932-26-005329 | EDGAR | 1K words |
| 2025-12-31 | 0001477932-25-009277 | EDGAR | 1K words |
| 2025-12-19 | 0001477932-25-009094 | EDGAR | 1K words |
| 2025-11-12 | 0001477932-25-008027 | EDGAR | 1K words |
| 2025-10-31 | 0001477932-25-007849 | EDGAR | 13K words |
| 2025-05-06 | 0001477932-25-003370 | EDGAR | 1K words |
| 2025-04-11 | 0001477932-25-002645 | EDGAR | 1K words |
| 2025-03-14 | 0001477932-25-001737 | EDGAR | 1K words |
| 2025-03-07 | 0001477932-25-001537 | EDGAR | 13K words |
209 total filings indexed. 177 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001187953 |
| Ticker | CELZ |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NV |
| Website | https://www.creativemedicaltechnology.com |
| Listed | 2009-04-30 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CELZ (~200 tokens, structured JSON with cryptographic provenance)